Wogonoside can reduce liver fibrosis by triggering hepatic stellate cell iron death through SOCS1/P53/SLC7A11 pathway [48], and has a protective effect on lipopolysaccharide/D-galactosamine-induced acute liver injury in mice [49]. The gene discussed is TP53; the disease is Hepatic fibrosis.